97376850 - LOGICA

Information

• Trademark
• 97376850

• Source

• Serial Number

  97376850

• Registration Number

  7171333

• International Classifications

  • 42 - Scientific and technological services and research and design relating thereto

• Filing Date

  April 22, 2022
  2 years ago

• Registration Date

  September 19, 2023
  a year ago

• Transaction Date

  January 10, 2024
  11 months ago

• Status Date

  September 19, 2023
  a year ago

• Published for Opposition Date

  December 06, 2022
  2 years ago

• Location Date

  August 16, 2023
  a year ago

• First Use Anywhere Date

  April 27, 2022
  2 years ago

• First Use In Commerce Date

  April 27, 2022
  2 years ago

• Status Code

  700

• Current Location

  PUBLICATION AND ISSUE SECTION

  Employee Name

  TORRES, MIGUEL A

• Attorney Docket Number

  057670

  Attorney Name

  Joseph V. Myers III

  Law Office Assigned Location Code

  O10

• Owners

  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC
  • VALO HEALTH, INC

Case File Statements

• PM0001: LOGICAL
• TR0010: The English translation of "LOGICA" in the mark is LOGIC.
• GS0421: Pharmaceutical drug development services; Pharmaceutical drug development services via software using artificial intelligence; Pharmaceutical drug development services via software using machine learning; Preclinical drug discovery and development services used for identifying, designing and/or optimizing chemical compounds; Preclinical drug discovery and development services used for identifying, designing and/or optimizing chemical compounds via software using artificial intelligence; Preclinical drug discovery and development services used for identifying, designing and/or optimizing chemical compounds via software using machine learning; Pharmaceutical evaluation and preclinical evaluation of chemical series or lead compounds in drug discovery; Pharmaceutical evaluation and preclinical evaluation of chemical series or lead compounds in drug discovery via software using artificial intelligence; Pharmaceutical evaluation and preclinical evaluation of chemical series or lead compounds in drug discovery via software using machine learning; Pharmaceutical drug development and discovery services, namely, identifying, designing, optimizing, and developing chemical lead series or lead compounds via software using artificial intelligence, machine learning, computational modeling, DNA-encoded library screening platform, high-throughput screening, medicinal chemistry, ADME, biology, pharmacology and/or non-GLP safety testing

Case File Event Statements

• 9/19/2023 - a year ago

  22 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC

• 9/19/2023 - a year ago

  21 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 8/17/2023 - a year ago

  20 - NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Type: SUNA

• 8/16/2023 - a year ago

  19 - ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Type: CNPR

• 7/18/2023 - a year ago

  18 - STATEMENT OF USE PROCESSING COMPLETE Type: SUPC

• 6/21/2023 - a year ago

  17 - USE AMENDMENT FILED Type: IUAF

• 7/18/2023 - a year ago

  16 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU

• 6/21/2023 - a year ago

  15 - TEAS STATEMENT OF USE RECEIVED Type: EISU

• 1/31/2023 - a year ago

  14 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM

• 12/6/2022 - 2 years ago

  13 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 12/6/2022 - 2 years ago

  12 - PUBLISHED FOR OPPOSITION Type: PUBO

• 11/16/2022 - 2 years ago

  11 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 11/2/2022 - 2 years ago

  10 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 10/8/2022 - 2 years ago

  9 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 10/7/2022 - 2 years ago

  8 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 10/7/2022 - 2 years ago

  7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 10/6/2022 - 2 years ago

  6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 10/6/2022 - 2 years ago

  5 - NON-FINAL ACTION E-MAILED Type: GNRT

• 10/6/2022 - 2 years ago

  4 - NON-FINAL ACTION WRITTEN Type: CNRT

• 9/23/2022 - 2 years ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 4/27/2022 - 2 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 4/26/2022 - 2 years ago

  1 - NEW APPLICATION ENTERED Type: NWAP